Compound information
- Natural Products
- ZC945116
- Molecular Formula
- C15H21FN2O4S
- Molecular Weight
- 344.120606372 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-fluorophenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C15H21FN2O4S/c1-15(2,3)22-14(19)17-8-10-18(11-9-17)23(20,21)13-6-4-12(16)5-7-13/h4-7H,8-11H2,1-3H3
- InChI Key
- CLCFATZMABJSNA-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccc(F)cc2)CC1
- Source
- ZINC000006761758
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 2.45 |
LogS | -3.362 | LogD | 3.358 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.054 | Pgp substrate | 0.012 |
HIA | 0.972 | F20 % | 0.994 |
F30 % | 0.974 | Caco-2 | -4.391 |
MDCK | -4.785 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.864 | PPB | 92.072 |
VD | 2.286 | Fu | 0.694 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.04 | CYP1A2 substrate | 0.478 |
CYP2A6 substrate | 0.634 | CYP2B6 substrate | 0.661 |
CYP2C19 inhibitor | 0.891 | CYP2C19 substrate | 0.837 |
CYP2C8 substrate | 0.669 | CYP2C9 inhibitor | 0.523 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.057 |
CYP2D6 substrate | 0.885 | CYP2E1 substrate | 0.894 |
CYP3A4 inhibitor | 0.117 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.231 | CL | 7.175 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.848 | Hepatotoxicity | 0.993 |
Mutagenicity | 0.23 | Rat Oral Acute Toxicity | 0.267 |
FDAMDD | 0.061 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.95 | Eye Corrosion | 0.013 |
Eye Irritation | 0.049 | Respiratory Toxicity | 0.237 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.754 | IGC50 | 2.915 |
LC50FM | 2.04 | LC50DM | 3.365 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.229 | NR-AR-LBD | 0.29 |
NR-AhR | 0.031 | NR-Aromatase | 0.411 |
NR-ER | 0.242 | NR-ER-LBD | 0.391 |
NR-PPAR-gamma | 0.122 | SR-ARE | 0.763 |
SR-ATAD5 | 0.385 | SR-HSE | 0.07 |
SR-MMP | 0.019 | SR-p53 | 0.027 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.